Final regulations on e-pharmacy likely by month-end: DGCI

Image
Press Trust of India Panaji
Last Updated : Dec 07 2018 | 6:25 PM IST

The union government is expected to come out with final regulations for the companies selling medicines online by the end of this month, Drugs Controller General of India Eswara Reddy said Friday.

The aim is to regulate online sale of medicines across the country and provide patients accessibility to genuine drugs from authentic portals only.

He said they already have examined the comments of stakeholders on draft regulations, which were released in September.

"The biggest hurdle for the growth of online pharmacy is that we do not have any regulations. By the end of this month, the government is going to finalise the regulations," he said here at the Global Venture Summit.

Currently, there are no regulations for such entities.

Regulations will help investors understand risk and benefits of investing in the sector, he added.

Currently, the market size of retail sale of medicines is about Rs 1.2 lakh crore. The market size of online sale of medicines is about Rs 3,500 crore, and is expected to increase to Rs 25,000 crore in the next 3-4 years, he said.

The habit-forming drugs (narcotic and psychotropic substances) would not be allowed to sale through this platform, he added.

In September, the Union health ministry came out with draft rules on sale of drugs by e-pharmacies.

According to the draft rules on 'sale of drugs by e-pharmacy', no person will be allowed to distribute or sell, stock, exhibit or offer for sale of drugs through e-pharmacy portal unless registered.

"Any person who intends to conduct business of e-pharmacy shall apply for the grant of registration to the Central Licensing Authority in Form 18AA through the online portal of the Central government," the draft notification had said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 07 2018 | 6:25 PM IST

Next Story